NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 81 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is 2,040.10 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $20,000 | 0.0% | 85,500 | 0.0% | 0.00% | – |
| Q2 2018 | $20,000 | -91.5% | 85,500 | -86.8% | 0.00% | -100.0% |
| Q1 2018 | $234,000 | +0.4% | 649,880 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $233,000 | -13.7% | 649,880 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $270,000 | -18.4% | 649,880 | 0.0% | 0.00% | -25.0% |
| Q2 2017 | $331,000 | -11.7% | 649,880 | 0.0% | 0.00% | -20.0% |
| Q1 2017 | $375,000 | -8.1% | 649,880 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $408,000 | -31.4% | 649,880 | 0.0% | 0.01% | -44.4% |
| Q3 2016 | $595,000 | +72.5% | 649,880 | 0.0% | 0.01% | +80.0% |
| Q2 2016 | $345,000 | -43.8% | 649,880 | 0.0% | 0.01% | -50.0% |
| Q1 2016 | $614,000 | -28.9% | 649,880 | 0.0% | 0.01% | -37.5% |
| Q4 2015 | $864,000 | -41.7% | 649,880 | 0.0% | 0.02% | -48.4% |
| Q3 2015 | $1,482,000 | +41.7% | 649,880 | 0.0% | 0.03% | +47.6% |
| Q2 2015 | $1,046,000 | +1.3% | 649,880 | 0.0% | 0.02% | 0.0% |
| Q1 2015 | $1,033,000 | -26.3% | 649,880 | -12.4% | 0.02% | -34.4% |
| Q4 2014 | $1,402,000 | +116.0% | 741,780 | +50.8% | 0.03% | +100.0% |
| Q3 2014 | $649,000 | -10.9% | 491,780 | 0.0% | 0.02% | -15.8% |
| Q2 2014 | $728,000 | -17.4% | 491,780 | +3.3% | 0.02% | -24.0% |
| Q1 2014 | $881,000 | – | 475,980 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|